| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
ID: ALA5281233
Max Phase: Preclinical
Molecular Formula: C18H9Cl2N5O3
Molecular Weight: 414.21
Associated Items:
Representations
Canonical SMILES: N#Cc1nn(-c2cc(Cl)c(-n3ccc4ccc(O)cc43)c(Cl)c2)c(=O)[nH]c1=O
Standard InChI: InChI=1S/C18H9Cl2N5O3/c19-12-5-10(25-18(28)22-17(27)14(8-21)23-25)6-13(20)16(12)24-4-3-9-1-2-11(26)7-15(9)24/h1-7,26H,(H,22,27,28)
Standard InChI Key: HHRQVHZZLFKWRK-UHFFFAOYSA-N
Associated Targets(Human)
THRA Tclin Thyroid hormone receptor alpha (894 Activities)
THRB Tclin Thyroid hormone receptor beta-1 (7926 Activities)
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
Molecule Features
| Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
| Molecule Type: | Topical: No | First In Class: No | Black Box: No |
| Chirality: No | Availability: No | Prodrug: No |
Drug Indications
| MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
|---|
Mechanisms of Action
| Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
|---|
Properties
| Molecular Weight: 414.21 | Molecular Weight (Monoisotopic): 413.0082 | AlogP: 2.75 | #Rotatable Bonds: 2 |
| Polar Surface Area: 116.70 | Molecular Species: ACID | HBA: 7 | HBD: 2 |
| #RO5 Violations: 0 | HBA (Lipinski): 8 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): 0 |
| CX Acidic pKa: 5.65 | CX Basic pKa: | CX LogP: 4.09 | CX LogD: 2.54 |
| Aromatic Rings: 4 | Heavy Atoms: 28 | QED Weighted: 0.52 | Np Likeness Score: -1.01 |
References
| 1. Hu L, Gu Y, Liang J, Ning M, Yang J, Zhang Y, Qu H, Yang Y, Leng Y, Zhou B.. (2023) Discovery of Highly Potent and Selective Thyroid Hormone Receptor β Agonists for the Treatment of Nonalcoholic Steatohepatitis., 66 (5): [PMID:36799411] [10.1021/acs.jmedchem.2c01669] |
Source
Source(1):